The DEA Houston Division, alongside Harris County District Attorney Kim Ogg, announced a major methamphetamine bust in north Houston, seizing drugs valued at $2 million.

The results add to evidence that the drug, tirzepatide, can be used as an effective weight loss aid.

The Centers for Medicare and Medicaid (CMS) are drastically cutting down on who can get Aduhelm, limiting it only to people enrolled in clinical trials.

U.S. health officials say Merck's experimental COVID-19 pill is effective but they raised questions about its safety during pregnancy.

A new drug, Aducanumab, was approved by the FDA earlier this month. It allegedly slows the rate of Alzheimer’s progress.

WOODLANDS, Texas – A Houston firefighter's family is hoping a new drug will help him win his battle with COVID-19. According to the U.S. National Library of Medicine, there are four hospitals across the country experimenting with the drug. Now, the company that makes the drug, NeuroRX, says they believe by using it as an injection, it can be used for conditions like bipolar depression and also respiratory distress. The department said they got approval from NeuroRX to get the drug transferred from Houston Methodist to Memorial Hermann in the Woodlands to treat Capt. Pena added that, right now, 96 Houston firefighters are in quarantine and 34 firefighters have tested positive.

HOUSTON – The U.S. Food and Drug Administration has fast-tracked a promising drug to treat COVID-19 patients and it is in trial at Houston Methodist Hospital. The drug is called RLF-100 and is also known as aviptadil. It has been approved by the FDA for emergency use at multiple clinical sites in patients who are too ill to enter the FDA’s Phase 2/3 trials. According to a press release from the drug maker NeuroRX, independent researchers have reported that aviptadil blocked replication of the SARS coronavirus in human lung cells and monocytes. The drug has been successful in reducing lung inflammation and so the FDA now says any doctor at any hospital can request this treatment to help severely ill COVID-19 patients.

(CNN) – The federal government is stuck with 63 million doses of hydroxychloroquine now that the US Food and Drug Administration has revoked permission for the drug to be distributed to treat coronavirus patients. The government started stockpiling donated hydroxychloroquine in late March, after President Trump touted it as "very encouraging" and "very powerful" and a "game-changer." That leaves the Strategic National Stockpile with 63 million doses of hydroxychloroquine, plus another 2 million doses of chloroquine, a related drug donated by Bayer, according to Carol Danko, a spokesperson for the US Department of Health and Human Services. Before the FDA revoked its authorization, the stockpile had already distributed 31 million doses. Novartis and Mylan donated doses of the drug to the stockpile.

Nearly 10 million Americans suffer from osteoporosis, and now a new drug may be about to change the way it's treated. It doesn't have a formal name yet but when injected daily, it reduces fractures and increases bone density in patients. The drug appears to reverse the affects of osteoporosis by stimulating cells to create new bone. "The ability to improve bone quality is a new concept and that's what this agent does," Dr. Paul Miller with Centura Health Physician Group says. Read more at KUSA